Cancer and Metastasis Reviews (ISSN 0167-7659) is a prestigious quarterly journal published by Springer in the United States, dedicated to advancing the understanding of cancer biology and metastasis through high-quality, systematic reviews. As a non-open access publication indexed in the Science Citation Index (SCI), the journal maintains a consistently high impact factor and is typically ranked in the second or third quartile of the Chinese Academy of Sciences journal classification for medicine and oncology, reflecting its strong standing in the academic community. The scope of the journal encompasses a broad spectrum of interdisciplinary research, including fundamental mechanisms of metastasis, therapeutic strategies, and clinical translation, thereby bridging the gap between basic science and clinical application. By prioritizing comprehensive summaries of frontier developments over original experimental studies, Cancer and Metastasis Reviews serves as a critical resource for senior researchers and clinicians seeking authoritative insights into the field. Although its subscription-based model may limit immediate dissemination compared to open-access alternatives, the journal’s rigorous editorial standards and focus on synthesizing complex data ensure it remains a highly competitive and respected venue for experts aiming to contribute to the broader discourse on cancer metastasis.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com